Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia Corporate Presentation March 2021 from adocia

Latest Press Releases

2021/06/15ADOCIA Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 81st Scientific Sessions
2021/06/10Number of shares and voting rights of ADOCIA as of May 31st, 2021

All Press releases

Next events

June 21-22, 2021 Kepler Cheuvreux Digital Event: Life Science Days - To provide an opportunity to biotech companies to present our business models and key success factors to institutional investors.

TOP